Latest Breaking News On - Jules abrahamjqa partners inc - Page 1 : comparemela.com

DepYmed to Meet with Investors at the Life Sciences Summit in New York City October 11, 2023

DepYmed to Meet with Investors at the Life Sciences Summit in New York City October 11, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAlexandria centerCold spring harbor laboratoryBiotechnology at stony brook universityJules abrahamjqa partners incLife sciences summitorganizedDepymed incLife sciences summitCompany showcaseLife sciencesNew york city octoberStony brook universityNymed incRett syndromeCold spring harbor

ADvantage Therapeutics Secures Approvals for Clinical Trial of AD04™ in Alzheimer s Disease Treatment in Poland, Bulgaria, and Slovakia

ADvantage Therapeutics Secures Approvals for Clinical Trial of AD04™ in Alzheimer s Disease Treatment in Poland, Bulgaria, and Slovakia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAchim schneebergerJeffrey maddenGlobe newswire advantage therapeutics incAlzheimer disease cooperative studyScottish medicines consortiumNational institute for healthWorld health organizationJules abrahamjqa partners incAdvantage therapeutics incClinical trial applicationNeuropsychiatric inventoryDisease cooperative studyDaily living standardsInnovation passport

DepYmed to Present Early Data on Its Small Molecule PTP1B Inhibitor Program at the 2023 IRSF Rett Syndrome Scientific Meeting

DepYmed to Present Early Data on Its Small Molecule PTP1B Inhibitor Program at the 2023 IRSF Rett Syndrome Scientific Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCold spring harbor laboratoryNashville marriott at vanderbilt university inDepymed incDrug administrationRett syndrome research foundationJules abrahamjqa partners incInternational rett syndrome associationInternational rett syndrome foundationWall streetRett syndrome foundationRett syndrome scientificNashville marriottVanderbilt universityRett syndrome

Qualigen Therapeutics Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael poirierUniversity of louisville uofl research foundationQualigen therapeutics incJules abrahamjqa partners incQualigen incAboutqualigentherapeutics incUniversity of louisvilleAmerican society of clinical oncologyWall streetFeature preclinicaldataPancreatic cancerLuminalb breastOrphan drug designationAmerican societyClinical oncology

Data on Potential Biomarker for Qualigen Therapeutics Lead Program QN-302 Published in Peer-Reviewed Journal Molecules

Data on Potential Biomarker for Qualigen Therapeutics Lead Program QN-302 Published in Peer-Reviewed Journal Molecules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTariq arshadExchange commissionJules abrahamjqa partners incQualigen therapeutics incAboutqualigentherapeutics incWall streetGene expression may be markerAnti tumor activityOrphan drug designationChief medical officerQualigen therapeuticsFast trackOrphan drugPrivate securities litigation reform act